Condor Software Secures $24 Million in Series A Funding

Condor Software, a San Diego-based company specializing in financial intelligence platforms for the life sciences sector, has successfully raised $24 million in a Series A funding round. The round was led by Insight Partners, a globally recognized software investor. Other participants in the funding included Felicis, 645 Ventures, Pamir Ventures, SNR Ventures, Prebys Ventures, and Bramalea Partners.

Founded by Jennifer Kyle, who also serves as the CEO, Condor Software is focused on developing an AI-powered platform that integrates clinical, operational, and financial data. This integration aids pharmaceutical and biotech companies in managing the financial aspects of developing new therapies more effectively.

Platform Capabilities

Condor Software's platform is designed to address the inefficiencies in financial decision-making within clinical trials, which often rely on fragmented data and manual processes. The platform offers three core modules:

  • Connect: Unifies clinical and financial data into a single system.
  • Compass: Provides forecasting, scenario modeling, and risk insights.
  • Copilot: Automates accruals, reconciliations, and month-end close processes.

Currently, the platform manages over $19 billion in R&D spending for organizations such as Acadia Pharmaceuticals, Alumis Therapeutics, BridgeBio Pharma, and Madrigal Pharmaceuticals. Customers have reported significant improvements, including over 90 percent forecast accuracy and 70 percent faster month-end close processes.

Use of Funds

The newly secured funds will be directed towards expanding Condor Software’s platform capabilities and enhancing its features to better serve large pharmaceutical companies. The company also plans to grow its engineering, product, design, sales, and customer success teams to support this expansion.

Jennifer Kyle commented on the challenges faced by the industry: "I’ve seen firsthand that therapies save lives. Too often though, promising therapies are killed in budget meetings by data that’s months out of date. This isn’t a science problem; it’s a financial visibility problem."

Conclusion

With this substantial investment, Condor Software is well-positioned to continue its mission of improving financial decision-making processes in the life sciences industry. The company's innovative approach to integrating diverse data sets into a cohesive platform marks a significant step forward in enhancing the efficiency and effectiveness of clinical trials.